Company Analysis

Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2017
Grade4.7
◀ Past 5.3● Present 4.9▶ Future 3.8
1 est.

Who runs Arcus Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rosen Terry J
Chief Executive Officer. First filing Mar 2018, latest Jan 26, 2026, 15 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
26 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Azoy AlexanderChief Accounting OfficerMar 2023Aug 24, 20266 · $400,000
Jaen Juan C.PresidentMar 2018Jul 13, 202621 · $9.2M
Tang Carolyn C.General CounselDec 2020Jun 12, 20262 · $300,000
Goeltz II Robert C.Chief Financial OfficerAug 2020May 12, 20266 · $900,000
Rosen Terry JChief Executive OfficerMar 2018Jan 26, 20262 · $1.2M
Jarrett JenniferChief Operating OfficerMar 2018Jan 26, 20265 · $2.2M
Markus RichardChief Medical OfficerFeb 2025Jan 26, 20262 · $200,000
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Falberg Kathryn EdirectorMar 2018Jun 12, 2026none
Kaneko YasunoridirectorMar 2018Jun 12, 2026none
Lacey David L.directorMay 2020Jun 12, 2026none
Lambert NicoledirectorAug 2021Jun 12, 2026none
Machado PatrickdirectorDec 2019Jun 12, 2026none
Perlman Andrew JdirectorDec 2020Jun 12, 2026none
Ribas AntonidirectorOct 2019Jun 12, 2026none
Earlier names on the record28, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton RCUS · research, not advice